SMTL ID : 8c13.1

Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x SYF: (2~{S},4~{R})-1-[(2~{S})-2-[3-[2-[2-[2-(acetamidomethyl)-4-(6,7-dihydro-5~{H}-pyrrolo[1,2-a]imidazol-2-yl)phenoxy]ethoxy]ethoxy]propanoylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)

SYF.1: 14 residues within 4Å: Chain C: N.14, P.33, W.35, F.38, Y.45, P.46, L.48, R.54, I.56, H.57, S.58, Y.59, H.62, W.64 13 PLIP interactions: 13 interactions with chain C Hydrophobic interactions: C:W.35, C:Y.45, C:Y.45, C:I.56, C:I.56, C:Y.59, C:W.64 Hydrogen bonds: C:N.14, C:Y.45, C:R.54, C:S.58, C:Y.59, C:Y.59

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kraemer, A. et al., Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48. To Be Published

Release Date

2022-12-28

Peptides

Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
J

B
K

C
L

Elongin-B

Elongin-C

von Hippel-Lindau disease tumor suppressor

Related Entries With Identical Sequence